SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 27, 2003
----------------
Strategic Diagnostics Inc.
-----------------------------------------------
(Exact Name of Registrant Specified in Charter)
Delaware 000-68440 56-1581761
--------------- ---------------- -------------------
(State or Other (Commission File (I.R.S. Employer
Jurisdiction of Number) Identification No.)
Incorporation)
111 Pencader Drive
Newark, DE 19702
---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (302) 456-6789
--------------
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
Items (a) and (b) are inapplicable.
(c) Exhibits.
Exhibit Number Exhibit Title
-------------- -------------
99 Press release issued by Strategic Diagnostics Inc. on
January 27, 2003
Item 9. Regulation FD Disclosure.
On January 27, 2003, Strategic Diagnostics Inc. issued a press release
announcing certain developments regarding its E. coli and salmonella testing
products. The press release is attached as an exhibit to this Current Report on
Form 8-K and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
STRATEGIC DIAGNOSTICS INC.
By: /s/ Stanley J. Musial
-----------------------
Stanley J. Musial
Chief Financial Officer
Dated: January 28, 2003
EXHIBIT INDEX
Exhibit Number Exhibit Title
-------------- -------------
99 Press release issued by Strategic Diagnostics Inc. on
January 27, 2003